NewsStock Market

Clover Health Reports Strong Second Quarter 2023 Results; Highlights Improved Financial Performance and Guidance Ranges

Insurance revenue grew 17% compared to Q2’22, and second quarter Insurance MCR improved to 77.2% , bringing first half MCR to 81.9% Company reports Q2 Net Loss of $28.8 million , and Adjusted EBITDA profit of $10.0 million Improved 2023 guidance includes Insurance MCR of 83% – 85% , and Adjusted

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button